Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest
| Autor: | Joseph F. Plouffe, Barbara A. Hackman, Jon Schrock |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Microbiology (medical)
Legionella Erythromycin Microbial Sensitivity Tests Drug resistance Microbiology Anti-Infective Agents Species Specificity Levofloxacin medicine Humans Serotyping Legionella pneumophila Serogroup 1 Etest Ohio Antibacterial agent Bacteriological Techniques 4-Quinolones biology business.industry Drug Resistance Microbial General Medicine biochemical phenomena metabolism and nutrition bacterial infections and mycoses biology.organism_classification Virology Anti-Bacterial Agents respiratory tract diseases Ciprofloxacin Infectious Diseases bacteria Macrolides Legionnaires' Disease business medicine.drug |
| Zdroj: | Diagnostic Microbiology and Infectious Disease. 28:221-223 |
| ISSN: | 0732-8893 |
| DOI: | 10.1016/s0732-8893(97)00043-6 |
| Popis: | Isolates of Legionella from 98 patients with Legionnaires' disease hospitalized in Columbus, Ohio, USA between 1991 through 1995 were tested for antimicrobial susceptibility to macrolides and quinolones using the Etest. Most (87%) isolates were Legionella pneumophila serogroup 1. All isolates tested remain susceptible to erythromycin, azithromycin, clarithromycin, ciprofloxacin, ofloxacin, and levofloxacin. In vitro susceptibility testing of Legionella to representative macrolides and quinolones should be considered to detect the emergence of resistant isolates. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect